Caitlin R Rausch (Caitlin Rausch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ashley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, Koichi Takahashi, Ghayas C Issa, Hagop M Kantarjian, Courtney D D DiNardo, Caitlin R Rausch
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 130 (11) (2024)
Ashley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, Koichi Takahashi, Ghayas C Issa, Hagop M Kantarjian, Courtney D D DiNardo, Caitlin R Rausch
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer (2024)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Laura M Roccograndi, Alexandra R Lovell, Alessandra Ferrajoli, Philip A Thompson, Jan A Burger, William G Wierda, Nitin Jain, Caitlin R Rausch
Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation. Leukemia & lymphoma (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D D DiNardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Kayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, Nicholas James Short, Shilpa Paul, Nitin Jain, Jenessa Lee, J Michael Savoy, Farhad Ravandi, Elias J Jabbour
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals. Leukemia & lymphoma (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D D DiNardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D D DiNardo, Naval Daver, Naveen Pemmaraju, Maro Ohanian, Yesid Alvarado, Lianchun Xiao, Gheath Alatrash, Sanam Loghavi, Caitlin R Rausch, Gautam Borthakur, Marina Y Konopleva, Jorge E Cortes, Tapan Mahendra Kadia
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study. Blood cancer journal 11 (3) (2021)
Abhishek Maiti, Courtney D D DiNardo, Wei Qiao, Tapan Mahendra Kadia, Elias J Jabbour, Caitlin R Rausch, Naval G Daver, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Musa Yilmaz, Yesid Alvarado, Kathryn S Montalbano, Allison Wade, Rita E Maduike, Julio A Guerrero, Kenneth Vaughan, Carol A Bivins, Sherry Pierce, Jing Ning, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis. Cancer 127 (22) (2021)
Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Marina Y Konopleva, Courtney D D DiNardo, Naval G Daver, Naveen Pemmaraju, Rashmi Kanagal-Shamana, Xuemei Wang, Xuelin Huang, Sherry Pierce, Caitlin R Rausch, Jan Burger, Alessandra Ferrajoli, Nitin Jain, Uday Popat, Zeev Estrov, Srdan Verstovsek, Elias J Jabbour, Guillermo Garcia Manero, Hagop Kantarjian
Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. American journal of hematology 96 (8) (2021)
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, Rasoul Pourebrahim, Tapan Mahendra Kadia, Caitlin R Rausch, Ken Furudate, Naval G Daver, Yesid Alvarado, Maro Ohanian, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Yilmaz, Guilin Tang, Farhad Ravandi, Hagop M Kantarjian, Courtney D D DiNardo, Marina Y Konopleva
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax. Cancer 127 (20) (2021)
Caitlin R Rausch, Courtney D D DiNardo, Abhishek Maiti, Nadya J Jammal, Tapan Mahendra Kadia, Kayleigh R Marx, Gautam Borthakur, J Michael Savoy, Naveen Pemmaraju, Adam J DiPippo, Naval G Daver, Serena M Chew, Koiji Sasaki, Ghayas C Issa, Nicholas James Short, Koichi Takahashi, Maro N Ohanian, Jing Ning, Lianchun Xiao, Yesid Alvarado, Dimitrios P Kontoyiannis, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Cancer 127 (14) (2021)
Sangeetha Venugopal, Abhishek Maiti, Courtney D D DiNardo, Sanam Loghavi, Naval G Daver, Tapan Mahendra Kadia, Caitlin R Rausch, Yesid Alvarado, Maro Ohanian DO, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Ylimaz, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia. American journal of hematology 96 (5) (2021)
Abhishek Maiti, Courtney D D DiNardo, Naval G Daver, Caitlin R Rausch, Farhad Ravandi, Tapan Mahendra Kadia, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C Issa, Nicholas James Short, Musa Yilmaz, Guillermo Montalban-Bravo, Alessandra Ferrajoli, Elias J Jabbour, Nitin Jain, Maro Ohanian, Koichi Takahashi, Phillip A Thompson, Sanam Loghavi, Kathryn S Montalbano, Sherry Pierce, William G Wierda, Hagop M Kantarjian, Marina Y Konopleva
Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood cancer journal 11 (2) (2021)
Abhishek Maiti, Wei Qiao, Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Elias J Jabbour, Naval G Daver, Gautam Borthakur, Guillermo Garcia Manero, Sherry A Pierce, Kathryn S Montalbano, Naveen Pemmaraju, Kiran Naqvi, Maro Ohanian DO, Nicholas James Short, Yesid Alvarado, Koichi Takahashi, Musa Ylimaz, Nitin Jain, Steven M Kornblau, Michael Andreeff, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C Issa, Lucia Masarova, Philip A Thompson, Caitlin R Rausch, Jing Ning, Hagop M Kantarjian, Courtney D D DiNardo, Marina Y Konopleva
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. American journal of hematology 96 (3) (2020)
Caitlin R Rausch, Shilpa Paul
Optimizing patient selection for treatment-free remission. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2020)
Caitlin R Rausch, Elias J Jabbour, Hagop M Kantarjian, Tapan Mahendra Kadia
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management. Cancer 126 (6) (2019)
Courtney D D DiNardo, Caitlin R Rausch, Christopher Benton, Tapan Mahendra Kadia, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Wendy Covert, Kayleigh R Marx, Morgan Mace, Elias J Jabbour, Jorge Cortes, Guillermo Garcia-Manero, Farhad Ravandi, Kapil N Bhalla, Hagop M Kantarjian, Marina Konopleva
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. American journal of hematology 93 (3) (2017)